(Q43093212)

13 November 2017

Prognostic utility of cell cycle progression score in men with prostate cancer after primary external beam radiation therapy (English)

1 reference

13 November 2017

0 references

1 reference

Stephen J Freedland

1

1 reference

13 November 2017

Leah Gerber

2

1 reference

13 November 2017

Julia Reid

3

1 reference

13 November 2017

William Welbourn

4

1 reference

13 November 2017

Eliso Tikishvili

5

1 reference

13 November 2017

Jimmy Park

6

1 reference

13 November 2017

Adib Younus

7

1 reference

13 November 2017

Alexander Gutin

8

1 reference

13 November 2017

Zaina Sangale

9

1 reference

13 November 2017

Jerry S Lanchbury

10

1 reference

13 November 2017

Joseph K Salama

11

1 reference

13 November 2017

Steven Stone

12

1 reference

13 November 2017

language of work or name

English

0 references

publication date

5 June 2013

1 reference

International Journal of Radiation Oncology Biology Physics

13 November 2017

1 reference

13 November 2017

86

1 reference

13 November 2017

5

1 reference

13 November 2017

848-853

1 reference

Radical prostatectomy versus observation for localized prostate cancer

13 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710548

Combination external beam radiation and brachytherapy boost with androgen deprivation for treatment of intermediate-risk prostate cancer: long-term results of CALGB 99809.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710548

Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710548

Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710548

Predictive models in external beam radiotherapy for clinically localized prostate cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710548

Evaluation of ki-67 staining levels as an independent biomarker of biochemical recurrence after salvage radiation therapy for prostate cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710548

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710548

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710548

Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: evidence from the TROG 96.01 randomised controlled trial

15 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23755923

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.IJROBP.2013.04.043

1 reference

13 November 2017

1 reference

13 November 2017

1 reference